Enterprise League logo
Ten63 Therapeutics Logo

Ten63 Therapeutics

Durham, United States (US) · Health and Medical

Do you work at Ten63 Therapeutics?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

#drug discovery

#ai

Ten63 Therapeutics is a Health and Medical company based in Durham, United States (US), founded in 2018, with 30-50 employees. Ten63 Therapeutics's profile is verified on Enterprise League.

Overview

Ten63 Therapeutics is a Durham, North Carolina-based biotechnology company pioneering the future of cancer therapeutics. We are leveraging our proprietary AI-driven BEYOND platform to tackle previously undruggable targets, creating groundbreaking therapeutics and redefining what’s possible for patients.

Our mission is to develop durable responses against some of the world’s most lethal diseases, focusing on cancers where current treatments fall short. We’re scaling quantum simulations and fusing them with generative chemistry to identify novel drug candidates and overcome drug resistance – a key challenge in oncology.

What sets Ten63 apart is our unique ability to predict and overcome drug resistance, thanks to the BEYOND platform. We are committed to innovation and a patient-centric approach, exploring targets like Myc, KRas G12D, and DDR1/2 to deliver lasting impact. We value passion, teamwork, and determination to solve even what seems impossible.
Visit Official Website

Most teams do this before shortlisting


Contact Details

info@ten63tx.com

Durham, United States (US), Durham Fwy

Founded

2018

Company Type

Private Limited Company

Employees

30-50

Categories

Biopharma
Life Science
Biotechnology

Keywords

#drug discovery

#ai

Awards

• 2026 OpenSee all

Products

Default Product Image
Myc Degraders
Biotechnology

A novel therapeutic approach targeting Myc, a key driver of cancer development. These degraders eliminate Myc from cancer cells and the surrounding microenvironment, unleashing the immune system against notoriously hard-to-treat cancers.

N/A

Companies teams usually look at after Ten63 Therapeutics

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.